To investigate whether these combined molecular alterations also occur in vivo, we next examined a panel of 150 primary DLBCL samples for promoter methylation of MIR34A and MIR34B/C by MS-MCA. Here, MIR34A is linked to diffuse large B-cell lymphoma.